Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:45 PM
Ignite Modification Date:
2025-12-24 @ 10:45 PM
NCT ID:
NCT00335335
Eligibility Criteria:
Inclusion Criteria:
* Subject is ≥18 years old.
* Subject must have been referred for an elective coronary angiography for one of several specified conditions.
Exclusion Criteria:
* The subject has impaired renal function with a serum creatinine level ≥1.7 mg/dL (150 µmol/L). If the institution's practising guideline(s) regarding the serum creatinine limits for receiving radiologic contrast medium are lower than 1.7 mg/dL (150 µmol/L), the investigator should follow the practising guideline(s) of their institution.
Subject has a known allergy to iodinated contrast agent
Subject has atrial fibrillation/flutter or any irregular heart rhythm considered to interfere with temporal acquisition of cardiac CT images.
The subject's resting heart rate is 66-100 bpm and β-blocker therapy is contraindicated.
Use of nitroglycerin is contraindicated.
Subject has had a prior CABG procedure.
Subject has a metal cardiac stent in place or artificial heart valve(s).
Subject has had a prior pacemaker or internal defibrillator lead implantation. Subject must agree to discontinue metformin day of and for 48 hours after the CTA procedure.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00335335
Study Brief:
Protocol Section:
NCT00335335